• OTS
  • April 30, 2018
SHARE
Post Views: 807

Catuogno S, Esposito CL, Condorelli G, de Franciscis V.
Adv Drug Deliv Rev. 2018 Apr 6. pii: S0169-409X(18)30058-9

PubMed

Related articles

How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands

How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands

April 23rd, 2021
Recent progress in non-native nucleic acid modifications

Recent progress in non-native nucleic acid modifications

April 23rd, 2021
Antisense Technology: A Review.

Antisense Technology: A Review.

March 15th, 2021
Best practices to ensure robust investigation of circular RNAs: pitfalls and tips

Best practices to ensure robust investigation of circular RNAs: pitfalls and tips

March 15th, 2021
A Hitchhiker’s Guide to Click-Chemistry with Nucleic Acids

A Hitchhiker’s Guide to Click-Chemistry with Nucleic Acids

February 16th, 2021
Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012-2018

Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012-2018

January 30th, 2021